190 related articles for article (PubMed ID: 3955784)
1. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
3. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
[TBL] [Abstract][Full Text] [Related]
4. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Rosso A
Cancer; 1993 Sep; 72(5):1564-72. PubMed ID: 8394198
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
Wang YM; Guo LJ; Li LS; Li P; Zheng J; Li L
Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group.
Buccheri G; Ferrigno D
Lung Cancer; 1997 Aug; 18(1):57-70. PubMed ID: 9268948
[TBL] [Abstract][Full Text] [Related]
8. Oral second- and third-line lomustine-etoposide-cyclophosphamide chemotherapy for small cell lung cancer.
Lebeau B; Chouaïd C; Baud M; Masanès MJ; Febvre M
Lung Cancer; 2010 Feb; 67(2):188-93. PubMed ID: 19394109
[TBL] [Abstract][Full Text] [Related]
9. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
Joss RA; Alberto P; Hürny C; Bacchi M; Leyvraz S; Thürlimann B; Cerny T; Martinelli G; Stahel R; Ludwig C
Ann Oncol; 1995 Jan; 6(1):41-8. PubMed ID: 7536028
[TBL] [Abstract][Full Text] [Related]
10. No response improvement after sequential chemotherapy for small cell lung cancer.
Postmus PE; Sleijfer DT; Meinesz AF; Kerstjens HA; Lo GT; Sluiter HJ
Eur J Respir Dis; 1986 Apr; 68(4):279-85. PubMed ID: 3015648
[TBL] [Abstract][Full Text] [Related]
11. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M
Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
[No Abstract] [Full Text] [Related]
12. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
13. Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer.
Ardizzoni A; Canobbio L; Pronzato P; Repetto L; Serrano J; Benvenuto F; Simonassi C; Baracco F; Faravelli B; Nosenzo M
Chemioterapia; 1986 Dec; 5(6):416-9. PubMed ID: 3026668
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
Li DX; Chen XB
Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
[TBL] [Abstract][Full Text] [Related]
15. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL
J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030
[TBL] [Abstract][Full Text] [Related]
16. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
17. A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG).
Buccheri G; Ferrigno D
Eur J Cancer; 1994; 30A(10):1424-31. PubMed ID: 7833096
[TBL] [Abstract][Full Text] [Related]
18. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Athanassiades P; Bacoyiannes H; Kontoyiannes D
Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
[TBL] [Abstract][Full Text] [Related]
19. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Blayney DW; McGuire BW; Cruickshank SE; Johnson DH
Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
[TBL] [Abstract][Full Text] [Related]
20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
